Highlight the importance of reaching the target goal of LDL-C in extremely-high-risk ASCVD patients: follow the trend of combined use of lipid lowering medications.
10.3760/cma.j.cn112148-20200730-00606
- Author:
Ping YE
1
Author Information
1. Department of Cardiology, Second Medical Center, General Hospital of Chinese People's Liberation Army, Beijing 100853, China.
- Publication Type:Journal Article
- MeSH:
Arteriosclerosis;
Cholesterol, LDL;
Goals;
Humans;
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;
Lipids;
Risk Factors
- From:
Chinese Journal of Cardiology
2020;48(12):998-999
- CountryChina
- Language:Chinese
